DEUTSCHE BANK AG\ - PACIFIC BIOSCIENCES CALIF IN ownership

PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 101 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q1 2018. The put-call ratio across all filers is 2.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of PACIFIC BIOSCIENCES CALIF IN
ValueSharesWeighting
Q3 2023$1,333,453
-38.0%
159,695
-1.2%
0.00%0.0%
Q2 2023$2,149,759
-12.1%
161,636
-23.5%
0.00%0.0%
Q1 2023$2,445,985
+32.4%
211,225
-6.5%
0.00%0.0%
Q4 2022$1,847,625
+22.1%
225,871
-13.3%
0.00%0.0%
Q3 2022$1,513,000
+14.3%
260,659
-13.0%
0.00%0.0%
Q2 2022$1,324,000
-51.9%
299,472
-0.9%
0.00%0.0%
Q1 2022$2,751,000
-58.5%
302,301
-6.8%
0.00%
-66.7%
Q4 2021$6,635,000
-33.3%
324,294
-16.7%
0.00%
-40.0%
Q3 2021$9,951,000
-15.2%
389,507
+16.0%
0.01%
-16.7%
Q2 2021$11,736,000
+97.8%
335,638
+88.4%
0.01%
+100.0%
Q1 2021$5,933,000
+21.5%
178,146
-5.3%
0.00%0.0%
Q4 2020$4,882,000
+210.4%
188,187
+18.1%
0.00%
+200.0%
Q3 2020$1,573,000
+86.2%
159,372
-34.9%
0.00%0.0%
Q2 2020$845,000
+285.8%
244,788
+242.1%
0.00%
Q1 2020$219,000
-33.4%
71,563
+11.7%
0.00%
Q4 2019$329,000
+21.9%
64,065
+22.2%
0.00%
Q3 2019$270,000
-62.6%
52,427
-56.2%
0.00%
Q2 2019$722,000
-77.1%
119,627
-72.6%
0.00%
-100.0%
Q1 2019$3,150,000
-17.3%
435,950
-15.3%
0.00%
-33.3%
Q4 2018$3,807,000
-20.1%
514,514
-41.6%
0.00%
+200.0%
Q3 2018$4,767,000
+103.2%
881,359
+33.3%
0.00%0.0%
Q2 2018$2,346,000
+313.8%
661,386
+138.6%
0.00%
Q1 2018$567,000
-49.9%
277,214
-35.4%
0.00%
-100.0%
Q4 2017$1,131,000
-5.9%
428,979
+87.1%
0.00%0.0%
Q3 2017$1,202,000
+51.4%
229,262
+2.5%
0.00%0.0%
Q2 2017$794,000
-54.0%
223,592
-33.1%
0.00%0.0%
Q1 2017$1,727,000
+128.4%
334,327
+67.4%
0.00%0.0%
Q4 2016$756,000
-50.0%
199,682
+18.1%
0.00%0.0%
Q3 2016$1,513,000
+36.9%
169,129
+7.3%
0.00%0.0%
Q2 2016$1,105,000
-69.8%
157,582
-63.4%
0.00%
-66.7%
Q1 2016$3,662,000
-33.7%
431,065
+2.5%
0.00%
-25.0%
Q4 2015$5,522,000
+1568.3%
420,671
+361.9%
0.00%
Q3 2015$331,000
-74.4%
91,068
-59.5%
0.00%
-100.0%
Q2 2015$1,294,000
+18.6%
225,039
+20.2%
0.00%0.0%
Q1 2015$1,091,000
-15.0%
187,269
+14.3%
0.00%0.0%
Q4 2014$1,283,000
+67.5%
163,819
+4.7%
0.00%
Q3 2014$766,000
-0.5%
156,466
+25.2%
0.00%
-100.0%
Q2 2014$770,000
+6.6%
124,960
-7.5%
0.00%0.0%
Q1 2014$722,000
+70.3%
135,072
+66.2%
0.00%
Q4 2013$424,000
-52.3%
81,277
-49.6%
0.00%
-100.0%
Q3 2013$888,000161,1600.00%
Other shareholders
PACIFIC BIOSCIENCES CALIF IN shareholders Q1 2018
NameSharesValueWeighting ↓
Madrone Advisors, LLC 16,415,933$137,073,04129.47%
ORACLE INVESTMENT MANAGEMENT INC 1,638,395$13,680,5984.20%
Decheng Capital Management III (Cayman), LLC 1,463,872$12,223,3314.08%
VK Services, LLC 2,632,784$21,983,7462.93%
Iron Triangle Partners LP 1,800,000$15,030,0002.20%
BOURNE LENT ASSET MANAGEMENT INC 574,350$4,795,8222.11%
Deep Track Capital, LP 6,000,000$50,100,0001.93%
Jackson Square Partners, LLC 6,933,865$57,897,7731.93%
ARK Investment Management 29,822,440$249,017,3701.90%
Nikko Asset Management Americas, Inc. 13,447,666$112,153,5341.34%
View complete list of PACIFIC BIOSCIENCES CALIF IN shareholders